Astellas Wins EU Approval for Advanced Cancer Drug
PremiumCompany AnnouncementsAstellas Wins EU Approval for Advanced Cancer Drug
1M ago
Bicycle says 45% of patients respond to bladder cancer drug, EN reports
Premium
The Fly
Bicycle says 45% of patients respond to bladder cancer drug, EN reports
2M ago
Astellas Pharma Prices New Unsecured Bonds
Premium
Company Announcements
Astellas Pharma Prices New Unsecured Bonds
2M ago
Astellas Nears EU Approval for Groundbreaking Cancer Drug
PremiumCompany AnnouncementsAstellas Nears EU Approval for Groundbreaking Cancer Drug
3M ago
Astellas’ New Therapy Set to Transform Bladder Cancer Treatment
Premium
Company Announcements
Astellas’ New Therapy Set to Transform Bladder Cancer Treatment
3M ago
Astellas Pharma Advances Governance and Diversity
Premium
Company Announcements
Astellas Pharma Advances Governance and Diversity
4M ago
FDA grants orphan drug, pediatric exclusivities for Cresemba for IA, IM
PremiumThe FlyFDA grants orphan drug, pediatric exclusivities for Cresemba for IA, IM
8M ago
Seagen, Astellas and Merck announce FDA grants priority review to Padcev BLA
Premium
The Fly
Seagen, Astellas and Merck announce FDA grants priority review to Padcev BLA
11M ago
Twist in research pact with with Astellas, eligible for milestone payments
Premium
The Fly
Twist in research pact with with Astellas, eligible for milestone payments
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100